CBD can stress the liver, but the risk depends heavily on how much you take, what other medications you use, and whether your liver is already healthy. In a 2024 randomized clinical trial of healthy adults conducted by FDA investigators, 5.6% of participants taking CBD developed liver enzyme elevations more than three times the normal upper limit within about a month. None of the participants on placebo showed the same changes. The good news: these elevations were asymptomatic, and liver enzymes returned to normal within one to two weeks after stopping CBD.
What CBD Does to Your Liver
When you swallow CBD, your liver does the heavy lifting to process it. CBD undergoes what’s called first-pass metabolism, meaning the liver breaks down a large portion of the compound before it ever reaches your bloodstream. During that process, CBD interacts with several of the liver’s key processing enzymes, temporarily slowing them down. This matters because those same enzymes are responsible for metabolizing a wide range of medications and substances your body encounters daily.
CBD’s strongest inhibitory effect is on an enzyme involved in breaking down certain drugs and toxins. It also significantly slows enzymes that process common medications like blood thinners, anti-seizure drugs, antidepressants, and proton pump inhibitors used for acid reflux. This isn’t unique to CBD. Grapefruit juice famously does something similar with one of these same enzyme pathways. But CBD affects a broader range of enzymes than grapefruit does, which means the potential for interaction is wider.
How Dose Changes the Risk
Liver stress from CBD is dose-dependent, and the data is clear on where the risk climbs. In clinical trials of the prescription CBD product used for epilepsy, liver enzyme elevations above three times the normal limit occurred in about 3% of patients taking 10 mg per kilogram of body weight per day, and jumped to 16 to 18% in those taking 20 mg per kilogram per day. For a 150-pound adult, that higher dose translates to roughly 1,400 mg of CBD daily.
Most people using over-the-counter CBD products take far less than that. A typical consumer dose ranges from 10 to 50 mg per day, which is a fraction of the amounts tested in clinical trials. Still, the FDA trial that found the 5.6% liver enzyme elevation rate used doses “representative of those commonly reported by consumers of unregulated consumer products,” suggesting that even non-prescription levels of use carry some measurable risk.
The threshold where clinical monitoring is recommended is 300 mg of CBD per day. If you’re taking that much or more, periodic blood work to check liver enzymes is a reasonable precaution, especially in the first few months.
Valproate and Other Drug Interactions
The single biggest risk factor for CBD-related liver problems isn’t CBD alone. It’s combining CBD with other medications that also tax the liver. The clearest example comes from epilepsy trials where patients took CBD alongside valproate, a widely prescribed anti-seizure drug. Approximately 21% of patients on both drugs developed significant liver enzyme elevations, compared to just 3% taking CBD without valproate. The mechanism behind this combination’s toxicity still isn’t fully understood.
Because CBD slows down so many of the liver’s processing enzymes, it can effectively increase the concentration of other drugs in your bloodstream. This means your liver is working harder to handle the combined load. If you take any prescription medication regularly, particularly one processed by the liver, adding CBD to the mix is worth discussing with whoever prescribes your medication.
How CBD Compares to Common Pain Relievers
To put CBD’s liver risk in context, researchers have tested it head-to-head against acetaminophen (the active ingredient in Tylenol) using advanced human liver cell models. Acetaminophen at high doses caused clear, time-dependent liver cell death with significant increases in liver injury markers by day three. CBD at comparable test concentrations did not produce the same pattern. Liver injury markers in CBD-treated cells stayed near baseline levels, and in some cases, certain markers were actually lower than the control group.
That said, CBD did show early signs of stress to liver cells at the highest concentration tested by day seven, primarily through inflammatory signals and subtle structural changes. The takeaway: CBD is not harmless to the liver, but its direct toxicity to liver cells appears substantially lower than acetaminophen at equivalent exposure levels. The risk with CBD seems to be more about enzyme disruption and drug interactions than outright poisoning of liver tissue.
How Delivery Method Matters
Oral CBD, whether in capsules, oils, or edibles, creates the most liver exposure because it passes directly through the liver before entering general circulation. This first-pass metabolism is a bottleneck that concentrates CBD’s effects on liver enzymes. Formulations designed to improve absorption through the lymphatic system (the body’s network of vessels that transport fats) can partially bypass this liver bottleneck, reducing the metabolic burden.
Inhaled or sublingual (under-the-tongue) CBD enters the bloodstream more directly and may place less acute stress on the liver, though it still reaches the liver eventually through circulation. If liver impact is a concern for you, the route of administration is one variable worth considering.
Warning Signs to Watch For
The tricky part about CBD-related liver stress is that it’s usually silent. In clinical trials, participants with elevated liver enzymes didn’t feel sick. Their blood work caught the problem, not their symptoms. Elevations typically appeared after about two to three weeks of consistent use.
In rarer cases, particularly when high doses were started quickly (around 1,500 mg per day without gradual increase), some people developed a rash, nausea, vomiting, abdominal pain on the right side (where the liver sits), or fatigue. About 12% of participants in one high-dose study developed a skin rash when CBD was started at full dose without titration, though this was uncommon with a slower ramp-up.
Three factors increase your risk of liver enzyme elevation from CBD: taking more than 300 mg daily, having pre-existing liver conditions or already elevated liver enzymes, and taking other hepatotoxic medications simultaneously. If any of these apply and you plan to use CBD regularly, baseline blood work and periodic monitoring give you an objective way to catch problems early. When detected, reducing the CBD dose by half and rechecking within a week is typically sufficient to bring enzyme levels back down.